Currently, the pharmaceutical engineering industry is experiencing new opportunities for technological transformation. AI technology is being fully integrated into the entire process—from drug discovery and development to process optimization and quality control—significantly shortening R&D cycles and improving production precision. Green processes such as continuous-flow microreactors and biosynthesis have become standard practice, reducing energy consumption and waste emissions while enhancing production safety.
The localization of technologies in fields such as high-end formulations and biopharmaceuticals is accelerating. Synthetic biology is driving a shift in drug production from “extraction-based manufacturing” to “design-based manufacturing,” with modular and intelligent production models emerging as new industry trends. This places higher demands on pharmaceutical engineering design, construction compliance, and levels of intelligence.
Shanghai Hengze Engineering Technology Group has deep expertise in the pharmaceutical engineering sector, offering comprehensive capabilities in pharmaceutical engineering design, consulting, and construction support services. Strictly adhering to GMP regulations in the pharmaceutical industry and integrating intelligent and green design concepts, the company provides pharmaceutical enterprises with safe, compliant, and efficient engineering solutions to support the upgrading of the pharmaceutical manufacturing industry.